About Soleus Capital
Soleus Capital is a private equity firm founded in 2018. It is primarily based in Greenwich, United States. In the last 12 months, it has participated in 8 funding rounds.
A lot of funds co-invest with Soleus Capital, with names like RA Capital Management sharing a substantial percentage of its portfolio.
Soleus Capital has a team of 18 people, including 8 partners.
Key Metrics
Soleus Capital's Portfolio
They have invested in a total of 48 companies. Their most recent investment was in Bolt Biotherapeutics (Post IPO round) on Oct 23, 2026. Here is the most recent investment by Soleus Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Oct 23, 2026 | Post IPO | 5096 | ||
Oct 23, 2026 | Series E | 8951 | ||
Aug 12, 2026 | Conventional Debt | 3107 | - | |
Aug 11, 2026 | Series C | 5687 |
Here is the portfolio snapshot of Soleus Capital:
Investments by Year
The maximum number of investments were made in 2021
Team profile of Soleus Capital
Soleus Capital has a team of 18 members including 8 Partners and 1 Principal located in United States. Soleus Capital's team sits on the board of 1 company.Here is a list of top team members in Soleus Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Greenwich | - | ||
Partner | New York City | - | ||
Partner | New York City | - | ||
Partner | Greenwich | - | ||
Partner | New York City | - | ||
Partner | New York City | - | - | |
Partner | New York City | - | - | |
Partner | New York City | - | - | |
Principal | United States | - | - | |
Associate | New York City | - | ||
Associate | New York City | - | - |
Co-investors of Soleus Capital
Over the past 8 years, 169 investors have co-invested in Soleus Capital's portfolio companies.
- Top Co-investors of Soleus Capital: 169 investors entered a company along with Soleus Capital. These include investors like RA Capital Management (13 companies).
Soleus Capital News
•
Barings Provides Senior Secured Financing to Soleus Capital to Expand Healthcare Credit and Royalty PlatformTMC•Sep 10, 2026•Soleus Capital, Barings
•
Abcuro Secures $66 Million Series D Funding for IBM Clinical Trialhttps://www.clinicaltrialsarena.com/•Aug 19, 2026•Abcuro, New Leaf Venture Partners, Bain Capital Life Sciences, Aberdeen Group and 10 others
•
Bridge to Life Raises $110M to Advance Liver Perfusion System RolloutMedicalDeviceNetwork•Aug 12, 2026•Soleus Capital, Bridge to Life, Lauxera Capital Partners
•
The market value has soared by more than 1,300%. How can a pharmaceutical company that failed in phase III clinical trials "escape from death"?TMTpost•Jun 05, 2026•Soleus Capital, Perceptive Advisors, Adlai Nortye, MPM BioImpact and 1 other
•
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million MoreThe Motley Fool•May 30, 2026•Soleus Capital
•
Adlai Nortye Announces $150.0 Million Private PlacementGlobeNewswire•Apr 16, 2026•Perceptive Advisors, Soleus Capital, Adlai Nortye
•
Heidelberg Pharma Receives $20M Funding via Amended Royalty AgreementWebDisclosure•Mar 09, 2026•Heidelberg Pharma, Soleus Capital, Telix Pharma, HCRx and 1 other
•
Parabilis gets $305M to conquer 'undruggable' proteins after early successEndpoints•Jan 08, 2026•Parabilis Medicines, Johnson & Johnson, Frazier Life Sciences, Rock Springs Capital and 19 others
•
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 MillionBenzinga•Oct 10, 2025•Nantahala Capital Management, Stonepine, Soleus Capital, Quoin Pharmaceuticals and 4 others
•